Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease

Am J Clin Nutr. 1999 Nov;70(5):881-7. doi: 10.1093/ajcn/70.5.881.

Abstract

Background: Elevated blood homocysteine is a risk factor for cardiovascular disease. A 5-micromol/L increase is associated with an approximately 70% increase in relative risk of cardiovascular disease in adults. For patients with established risk factors, this risk is likely even greater.

Objective: Effects of increased dietary folate and recommended intakes of vitamins B-12 and B-6 on serum total homocysteine (tHcy) were assessed in individuals at high risk of cardiovascular disease.

Design: This trial was conducted at 10 medical research centers in the United States and Canada and included 491 adults with hypertension, dyslipidemia, type 2 diabetes, or a combination thereof. Participants were randomly assigned to follow a prepared meal plan (PMP; n = 244) or a self-selected diet (SSD; n = 247) for 10 wk, which were matched for macronutrient content. The PMP was fortified to provide >/=100% of the recommended dietary allowances for 23 micronutrients, including folate.

Results: Mean folate intakes at 10 wk were 601 +/- 143 microgram/d with the PMP and 270 +/- 107 microgram/d with the SSD. With the PMP, serum tHcy concentrations fell from 10.8 +/- 5.8 to 9.3 +/- 4.9 micromol/L (P < 0.0001) between weeks 0 and 10 and the change was associated with increased intakes of folate, vitamin B-12, and vitamin B-6 and with increased serum and red blood cell folate and serum vitamin B-12 concentrations. tHcy concentrations did not change significantly with the SSD.

Conclusions: The PMP resulted in increased intakes and serum concentrations of folate and vitamin B-12. These changes were associated with reduced serum tHcy concentrations in persons at high risk of cardiovascular disease.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Cardiovascular Diseases / etiology*
  • Diabetes Mellitus, Type 2 / complications
  • Diet*
  • Female
  • Folic Acid / administration & dosage
  • Folic Acid / therapeutic use*
  • Food, Fortified
  • Homocysteine / blood*
  • Humans
  • Hyperlipidemias / complications
  • Hypertension / complications
  • Male
  • Middle Aged
  • Pyridoxine / administration & dosage
  • Pyridoxine / therapeutic use*
  • Risk Factors
  • Vitamin B 12 / administration & dosage
  • Vitamin B 12 / therapeutic use*

Substances

  • Homocysteine
  • Folic Acid
  • Pyridoxine
  • Vitamin B 12